Form 4: Linda McGoldrick, Compass Pathways Director, Reports Share Option Grant
SEC Form 4 Filing
Director Linda McGoldrick reports acquisition of share options in Compass Pathways plc.
Summary
- Linda McGoldrick, a director of COMPASS Pathways plc, filed a Form 4 on May 13, 2024, reporting a transaction.
- On May 9, 2024, McGoldrick acquired 26,000 share options with an exercise price of $8.54.
- The options vest upon the earlier of the first anniversary of the grant date (May 9, 2025) or the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2025.
- The options expire on May 8, 2034.
- Following the transaction, McGoldrick directly owns 26,000 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, aligning director interests with shareholders through share options.
Positives
- The grant of share options to a director aligns their interests with those of the shareholders.
- The vesting schedule incentivizes continued service and contribution to the company's success.
Industry Context
This filing is a routine disclosure related to executive compensation and is common in the pharmaceutical industry, particularly for companies like Compass Pathways that are focused on innovative treatments and research.
Comparison to Industry Standards
- Share option grants are a standard component of executive compensation packages in the biotechnology and pharmaceutical industries.
- Companies like MindMed, Atai Life Sciences, and GH Research also utilize stock options to incentivize their executives and align their interests with shareholders.
- The vesting schedule and exercise price are typical for such grants, designed to reward long-term value creation.
Stakeholder Impact
- The grant of share options to a director can positively impact shareholders by aligning management's interests with the company's long-term success.
- It can also motivate the director to contribute to the company's growth and profitability.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of share option grant |
| 05/09/2025 | Earliest vesting date of share options (first anniversary of grant) |
| 05/08/2034 | Expiration date of share options |
| 05/13/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.